Skip to main content
Fig. 1 | BMC Infectious Diseases

Fig. 1

From: Peripheral blood correlates of virologic relapse after Sofosbuvir and Ribavirin treatment of Genotype-1 HCV infection

Fig. 1

Cellular changes during DAA therapy as measured in peripheral blood by flow cytometry and as predicted by gene expression analysis. a Changes in cellular populations determined by flow cytometry, as described in the methods section. Data are derived from up to 53 patients for each individual cell type. b Change in predicted cellular composition of total PBMCs using Nanonstring score. Data are derived from 36 patients. Significance was determined by paired t-test with designation on graphs of p < 0.05 (*), p < 0.005 (**), p < 0.0005 (***)

Back to article page